Tigan and Imitrex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tigan and Imitrex. Common interactions include humerus fracture among females and depression among males.

The phase IV clinical study analyzes what interactions people who take Tigan and Imitrex have. It is created by eHealthMe based on reports of 22 people who take Tigan and Imitrex from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 29, 2023

22 people who take Tigan and Imitrex together, and have interactions are studied.

What is Tigan?

Tigan has active ingredients of trimethobenzamide hydrochloride. It is often used in nausea. eHealthMe is studying from 1,870 Tigan users for its effectiveness, alternative drugs and more.

What is Imitrex?

Imitrex has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 17,127 Imitrex users for its effectiveness, alternative drugs and more.

Number of Tigan and Imitrex reports submitted per year:

Common Tigan and Imitrex drug interactions by gender *:

female:

Humerus fracture
Hypercalcaemia
Hyperplasia
Hypertension
Hyperventilation
Hypochondriasis
Hypotension
Impaired gastric emptying
Impaired work ability
Injection site haemorrhage

male:

Depression
Emotional distress
Oesophageal ulcer
Oesophagitis
Blood alkaline phosphatase nos increased
Blood amylase decreased
Dehydration
Drug effect decreased
Gastrointestinal motility disorder
Haematocrit decreased

Common Tigan and Imitrex drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Abdominal pain
Anxiety
Cholecystitis chronic
Cholelithiasis
Emotional distress
Injury
Pain
Dependence
Fall
Headache

40-49:

Drug ineffective
Injection site pain
Injection site swelling

50-59:

Oesophagitis
Blood alkaline phosphatase nos increased
Blood amylase decreased
Dehydration
Drug effect decreased
Gastrointestinal motility disorder
Haematocrit decreased
Haemoglobin abnormal
International normalised ratio decreased
Laboratory test abnormal

60+:

Abdominal mass
Affect lability
Burning sensation
Butterfly rash
Cataract
Choking
Chorea
Colonic polyp
Confusional state
Contusion

Common conditions people have *:

Depression: 6 people, 27.27%
Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 18.18%
Plantar Fasciitis (painful inflammatory process of the plantar fascia): 4 people, 18.18%
Joint Pain: 4 people, 18.18%
High Blood Pressure: 4 people, 18.18%
High Blood Cholesterol: 4 people, 18.18%
Headache (pain in head): 4 people, 18.18%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 18.18%
Diabetes: 4 people, 18.18%
Parkinson's Disease: 3 people, 13.64%

* Approximation only. Some reports may have incomplete information.

Do you take Tigan and Imitrex?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.